Paper: Change is in the air - the new pressurized metered-dose inhaler propellants
John is now a private consultant specialising in strategic approaches to developing respiratory devices, drugs and digital health. In addition, he is a Director for a number of SMEs including Acuflow, and sits on 4 Scientific Advisory Boards. At different stages in his career across GSK, 3M, AZ and Philips, he has worked on MDIs, DPIs and nebulized products, having been associated with the launch of 11 major products. He also sits on the UN Committee that makes recommendations on the medical uses of propellants covered by the Montreal Protocol. At RDD in April 2018, John received the Charles Thiel award for outstanding research and discovery in respiratory drug delivery.